NiTi Surgical introduces ColonRing surgical device

NiTi Surgical Solutions, a surgical device company, has launched the ColonRing, its new closure technology for colorectal surgery, in the US.

The current surgical standard for reconnecting the resected bowel involves surgical staples and stapling devices, which puncture tissue (more than 100 punctures), while creating an intermittent reconnection, and can also crush it. The ColonRing with BioDynamix Anastomosis technology is a new device intended to address the major drawbacks of circular staples.

The ColonRing is a medical device designed to help a patient’s body heal after colon surgery. Because anastomosis (the surgical connection of two parts of a hollow organ) with the ColonRing is staple-free, there are no bowel wall punctures, no risk of staple line bleeding, and no permanent foreign bodies in the bowel, said NiTi Surgical.

The safety and efficacy of the ColonRing device has been established in multiple clinical trials and in commercial use. The device has been used successfully throughout the bowel, from 4cm to more than 50cm from the anal verge and in a wide range of surgical procedures. The device received FDA clearance and CE Marking in Europe for use in colorectal and gastrointestinal surgeries.

Itay Itzhaky, CEO of NiTi Surgical Solutions, said: The launch of ColonRing in the US is an exciting and important milestone for NiTi. With our global reach, fully-integrated operations, and commitment to innovation, we have a unique opportunity to be the technology leader in bowel anastomosis as we continue to develop a broad portfolio of CE-marked and FDA-cleared surgical devices for tissue reconnection.